NEUROCRINE BIOSCIENCES INC Capital Expenditures Incurred but Not yet Paid
NEUROCRINE BIOSCIENCES INC (NBIX) reported Capital Expenditures Incurred but Not yet Paid of $1.30 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-31.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:CapitalExpendituresIncurredButNotYetPaid · last filed 2026-07-31
- NEUROCRINE BIOSCIENCES INC capital expenditures incurred but not yet paid for the quarter ending 2026-06-30 was -$100.00K.
- NEUROCRINE BIOSCIENCES INC capital expenditures incurred but not yet paid for the quarter ending 2026-03-31 was $1.40M, a 48.15% decline year-over-year.
- NEUROCRINE BIOSCIENCES INC capital expenditures incurred but not yet paid for the quarter ending 2025-12-31 was $1.60M, a 14.29% increase year-over-year.
- NEUROCRINE BIOSCIENCES INC capital expenditures incurred but not yet paid for the quarter ending 2025-09-30 was -$1.30M.
- NEUROCRINE BIOSCIENCES INC capital expenditures incurred but not yet paid for fiscal 2025 was $2.20M, a 0.00% change from fiscal 2024.
- NEUROCRINE BIOSCIENCES INC capital expenditures incurred but not yet paid for fiscal 2024 was $2.20M, a 12.00% decline from fiscal 2023.
- NEUROCRINE BIOSCIENCES INC capital expenditures incurred but not yet paid for fiscal 2023 was $2.50M, a 257.14% increase from fiscal 2022.
- NEUROCRINE BIOSCIENCES INC capital expenditures incurred but not yet paid for fiscal 2022 was $700.00K, a 63.16% decline from fiscal 2021.
| Period end | Capital Expenditures Incurred but Not yet Paid 3 month | Capital Expenditures Incurred but Not yet Paid 3 month as first filed | Capital Expenditures Incurred but Not yet Paid 6 month | Capital Expenditures Incurred but Not yet Paid 6 month as first filed | Capital Expenditures Incurred but Not yet Paid 9 month | Capital Expenditures Incurred but Not yet Paid 9 month as first filed | Capital Expenditures Incurred but Not yet Paid 12 month | Capital Expenditures Incurred but Not yet Paid 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$100.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-31 | $1.30M 10-Q · filed 2026-07-31 | $2.90M derived: sum of 3 quarters · filed 2026-07-31 | $1.60M derived: sum of 4 quarters · filed 2026-07-31 | ||||
| 2026-03-31 | $1.40M 10-Q · filed 2026-05-05 | $3.00M derived: sum of 2 quarters · filed 2026-05-05 | $1.70M derived: sum of 3 quarters · filed 2026-05-05 | $900.00K derived: sum of 4 quarters · filed 2026-07-31 | ||||
| 2025-12-31 | $1.60M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-11 | $300.00K derived: sum of 2 quarters · filed 2026-02-11 | -$500.00K derived: sum of 3 quarters · filed 2026-07-31 | $2.20M 10-K · filed 2026-02-11 | ||||
| 2025-09-30 | -$1.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-28 | -$2.10M derived: sum of 2 quarters · filed 2026-07-31 | $600.00K 10-Q · filed 2025-10-28 | $2.00M derived: sum of 4 quarters · filed 2026-07-31 | ||||
| 2025-06-30 | -$800.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-31 | $1.90M 10-Q · filed 2026-07-31 | $3.30M derived: sum of 3 quarters · filed 2026-07-31 | $800.00K derived: sum of 4 quarters · filed 2026-07-31 | ||||
| 2025-03-31 | $2.70M 10-Q · filed 2026-05-05 | $4.10M derived: sum of 2 quarters · filed 2026-05-05 | $1.60M derived: sum of 3 quarters · filed 2026-05-05 | $3.80M derived: sum of 4 quarters · filed 2026-05-05 | ||||
| 2024-12-31 | $1.40M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-11 | -$1.10M derived: sum of 2 quarters · filed 2026-02-11 | $1.10M derived: sum of 3 quarters · filed 2026-02-11 | $2.20M 10-K · filed 2026-02-11 | ||||
| 2024-09-30 | -$2.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-28 | -$300.00K derived: sum of 2 quarters · filed 2025-10-28 | $800.00K 10-Q · filed 2025-10-28 | $2.40M derived: sum of 4 quarters · filed 2026-02-11 | ||||
| 2024-06-30 | $2.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-30 | $3.30M 10-Q · filed 2025-07-30 | $4.90M derived: sum of 3 quarters · filed 2026-02-11 | $5.00M derived: sum of 4 quarters · filed 2026-02-11 | ||||
| 2024-03-31 | $1.10M 10-Q · filed 2025-05-05 | $2.70M derived: sum of 2 quarters · filed 2026-02-11 | $2.80M derived: sum of 3 quarters · filed 2026-02-11 | $3.00M derived: sum of 4 quarters · filed 2026-02-11 | ||||
| 2023-12-31 | $1.60M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-11 | $1.70M derived: sum of 2 quarters · filed 2026-02-11 | $1.90M derived: sum of 3 quarters · filed 2026-02-11 | $2.50M 10-K · filed 2026-02-11 | ||||
| 2023-09-30 | $100.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-30 | $300.00K derived: sum of 2 quarters · filed 2024-10-30 | $900.00K 10-Q · filed 2024-10-30 | $900.00K derived: sum of 4 quarters · filed 2025-02-10 | ||||
| 2023-06-30 | $200.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01 | $800.00K 10-Q · filed 2024-08-01 | $800.00K derived: sum of 3 quarters · filed 2025-02-10 | $600.00K derived: sum of 4 quarters · filed 2025-02-10 | ||||
| 2023-03-31 | $600.00K 10-Q · filed 2024-05-01 | $600.00K derived: sum of 2 quarters · filed 2025-02-10 | $400.00K derived: sum of 3 quarters · filed 2025-02-10 | -$1.50M derived: sum of 4 quarters · filed 2025-02-10 | ||||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-10 | -$200.00K derived: sum of 2 quarters · filed 2025-02-10 | -$2.10M derived: sum of 3 quarters · filed 2025-02-10 | $700.00K 10-K · filed 2025-02-10 | ||||
| 2022-09-30 | -$200.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-10-31 | -$2.10M derived: sum of 2 quarters · filed 2023-10-31 | $700.00K 10-Q · filed 2023-10-31 | $2.30M derived: sum of 4 quarters · filed 2024-02-09 | ||||
| 2022-06-30 | -$1.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-01 | $900.00K 10-Q · filed 2023-08-01 | $2.50M derived: sum of 3 quarters · filed 2024-02-09 | $600.00K derived: sum of 4 quarters · filed 2024-02-09 | ||||
| 2022-03-31 | $2.80M 10-Q · filed 2023-05-03 | $4.40M derived: sum of 2 quarters · filed 2024-02-09 | $2.50M derived: sum of 3 quarters · filed 2024-02-09 | $4.60M derived: sum of 4 quarters · filed 2024-02-09 | ||||
| 2021-12-31 | $1.60M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-09 | -$300.00K derived: sum of 2 quarters · filed 2024-02-09 | $1.80M derived: sum of 3 quarters · filed 2024-02-09 | $1.90M 10-K · filed 2024-02-09 | ||||
| 2021-09-30 | -$1.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-01 | $200.00K derived: sum of 2 quarters · filed 2022-11-01 | $300.00K 10-Q · filed 2022-11-01 | $600.00K derived: sum of 4 quarters · filed 2023-02-09 | ||||
| 2021-06-30 | $2.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $2.20M 10-Q · filed 2022-08-04 | $2.50M derived: sum of 3 quarters · filed 2023-02-09 | $2.70M derived: sum of 4 quarters · filed 2023-02-09 | ||||
| 2021-03-31 | $100.00K 10-Q · filed 2022-05-04 | $400.00K derived: sum of 2 quarters · filed 2023-02-09 | $600.00K derived: sum of 3 quarters · filed 2023-02-09 | $700.00K derived: sum of 4 quarters · filed 2023-02-09 | ||||
| 2020-12-31 | $300.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-09 | $500.00K derived: sum of 2 quarters · filed 2023-02-09 | $600.00K derived: sum of 3 quarters · filed 2023-02-09 | $1.40M 10-K · filed 2023-02-09 | ||||
| 2020-09-30 | $200.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-01 | $300.00K derived: sum of 2 quarters · filed 2021-11-01 | $1.10M 10-Q · filed 2021-11-01 | $2.00M derived: sum of 4 quarters · filed 2022-02-11 | ||||
| 2020-06-30 | $100.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-03 | $900.00K 10-Q · filed 2021-08-03 | $1.80M derived: sum of 3 quarters · filed 2022-02-11 | $1.00M derived: sum of 4 quarters · filed 2022-02-11 | ||||
| 2020-03-31 | $800.00K 10-Q · filed 2021-05-05 | $1.70M derived: sum of 2 quarters · filed 2022-02-11 | $900.00K derived: sum of 3 quarters · filed 2022-02-11 | $1.20M derived: sum of 4 quarters · filed 2022-02-11 | ||||
| 2019-12-31 | $900.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-11 | $100.00K derived: sum of 2 quarters · filed 2022-02-11 | $400.00K derived: sum of 3 quarters · filed 2022-02-11 | $1.00M 10-K · filed 2022-02-11 | $953.00K 10-K · filed 2020-02-07 | |||
| 2019-09-30 | -$800.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | -$500.00K derived: sum of 2 quarters · filed 2020-11-09 | $100.00K 10-Q · filed 2020-11-09 | $55.00K 10-Q · filed 2019-11-04 | $598.00K derived: sum of 4 quarters · filed 2021-02-05 | |||
| 2019-06-30 | $300.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-03 | $900.00K 10-Q · filed 2020-08-03 | $911.00K 10-Q · filed 2019-07-29 | $1.40M derived: sum of 3 quarters · filed 2021-02-05 | -$38.00K derived: sum of 4 quarters · filed 2021-02-05 | |||
| 2019-03-31 | $600.00K 10-Q · filed 2020-05-06 | $615.00K 10-Q · filed 2019-04-29 | $1.10M derived: sum of 2 quarters · filed 2021-02-05 | -$338.00K derived: sum of 3 quarters · filed 2021-02-05 | $2.90M derived: sum of 4 quarters · filed 2021-02-05 | |||
| 2018-12-31 | $498.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-05 | -$938.00K derived: sum of 2 quarters · filed 2021-02-05 | $2.30M derived: sum of 3 quarters · filed 2021-02-05 | $2.30M 10-K · filed 2021-02-05 | $2.32M 10-K · filed 2019-02-08 | |||
| 2018-09-30 | -$1.44M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-04 | $1.80M derived: sum of 2 quarters · filed 2019-11-04 | $1.80M 10-Q · filed 2019-11-04 | $1.80M derived: sum of 4 quarters · filed 2020-02-07 | ||||
| 2018-06-30 | $3.24M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-29 | $3.24M 10-Q · filed 2019-07-29 | $3.24M derived: sum of 3 quarters · filed 2020-02-07 | $3.24M derived: sum of 4 quarters · filed 2020-02-07 | ||||
| 2018-03-31 | $0.00 10-Q · filed 2019-04-29 | $0.00 derived: sum of 2 quarters · filed 2020-02-07 | $0.00 derived: sum of 3 quarters · filed 2020-02-07 | |||||
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-07 | $0.00 derived: sum of 2 quarters · filed 2020-02-07 | $0.00 10-K · filed 2020-02-07 | |||||
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-05 | $0.00 10-Q · filed 2018-11-05 | ||||||
| 2017-06-30 | $0.00 10-Q · filed 2018-07-31 | |||||||
| 2016-12-31 | $0.00 10-K · filed 2019-02-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |